OTCBB:ODYY
Odyssey Group International, Inc. Stock News
$0.0400
-0.0110 (-21.57%)
At Close: May 21, 2024
Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity
08:30am, Wednesday, 27'th Mar 2024
LAS VEGAS, NV / ACCESSWIRE / March 27, 2024 / Odyssey Health, Inc. (OTCQB:ODYY), formerly Odyssey Group International, Inc., (the "Company") a company focused on developing unique, life-enhancing medi
LAS VEGAS, NV / ACCESSWIRE / January 2, 2024 / Odyssey Health, Inc. (OTCQB:ODYY) ("Odyssey" or the "Company") today announces the closing of the definitive Asset Purchase Agreement, that was entered i
Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc.
08:30am, Tuesday, 12'th Dec 2023
LAS VEGAS, NV / ACCESSWIRE / December 12, 2023 / Odyssey Health, Inc. (OTCOB:ODYY), a company focused on developing unique, life-enhancing medical products including a drug treatment intended to treat
Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion
08:30am, Thursday, 16'th Nov 2023
LAS VEGAS, NV / ACCESSWIRE / November 16, 2023 / Odyssey Health, Inc. (OTCQB:ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, ha
Odyssey Health, Inc. to Provide Company Update and Webcast for Shareholders
12:00pm, Wednesday, 15'th Nov 2023
LAS VEGAS, NV / ACCESSWIRE / November 15, 2023 / Odyssey Health, Inc. (OTCQB:ODYY), formerly Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products,
Odyssey Health, Inc. Provides Update on Asset Purchase Agreement with Oragenics, Inc.
08:30am, Wednesday, 18'th Oct 2023
LAS VEGAS, NV / ACCESSWIRE / October 18, 2023 / Odyssey Health, Inc. (OTCQB:ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products is p
Odyssey Health Inc. Begins Trading on the OTCQB
08:30am, Wednesday, 04'th Oct 2023
LAS VEGAS, NV / ACCESSWIRE / October 4, 2023 / Odyssey Health, Inc. (formerly known as Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), is a medical device and pharmaceutic
Odyssey Group International Files Patent On Novel Breath-Propelled Nasal Delivery Device
10:03am, Tuesday, 19'th Oct 2021
IRVINE, CA, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical technology company focused on developing unique, life-saving medic
Odyssey Group International Begins Enrolling Subjects for Phase 1 Clinical Trial to Treat Concussion
08:39am, Wednesday, 22'nd Sep 2021
IRVINE, CA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY ) (the "Company" or "Odyssey"), a medical company focused on developing unique, life-saving medical products
Odyssey Group International Approved to Start Human Trial to Treat Concussion
08:30am, Wednesday, 01'st Sep 2021
IRVINE, CA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY ) (the "Company" or "Odyssey"), a company focused on developing unique, life-saving medical products, today
Odyssey Group International Completes IND-enabling Studies, Submits Investigator's Brochure for Phase 1 Clinical Trial
09:25am, Wednesday, 04'th Aug 2021
IRVINE, CA, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life
Odyssey Group International, Inc. Provides Notice of Annual Meeting of Stockholders
08:32am, Monday, 26'th Jul 2021
IRVINE, CA, July 26, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY) ("ODYY" or "the Company"), Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"),
Odyssey Group International Announces Successful Completion of Their Novel Nano-Particle Drug Formulation for Treating Concussion
07:30am, Wednesday, 02'nd Jun 2021
Irvine, CA, June 02, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, li
Odyssey Group International Announces Successful Toxicology Studies for its Concussion Drug
07:29am, Wednesday, 26'th May 2021
Enters Agreement with Contract Research Organization for Phase 1 Trial Enters Agreement with Contract Research Organization for Phase 1 Trial
Odyssey Group International, Inc. Schedules Annual Meeting of Stockholders
08:00am, Monday, 24'th May 2021
IRVINE, CA, May 24, 2021 (GLOBE NEWSWIRE) -- – Odyssey Group International, Inc. (OTCQB: ODYY) ("ODYY" or "the Company"), Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"
